STXBP3 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.28765919938223E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.72559999967304E-07 |
Normal-vs-Stage2 |
2.177000E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
5.837800E-03 |
Stage1-vs-Stage2 |
6.557400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.553200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
1.274410E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.84380305362697E-11 |
Normal-vs-AfricanAmerican |
7.764300E-02 |
Normal-vs-Asian |
8.106200E-02 |
Caucasian-vs-AfricanAmerican |
8.817500E-04 |
Caucasian-vs-Asian |
4.505800E-01 |
AfricanAmerican-vs-Asian |
1.039390E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.54339999997233E-06 |
Normal-vs-Female |
3.86590000012177E-07 |
Male-vs-Female |
6.408400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.243600E-04 |
Normal-vs-Extreme_Weight |
4.36580000000575E-05 |
Normal-vs-Obese |
2.039600E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.598400E-01 |
Normal_Weight-vs-Obese |
4.514600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.621000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.424200E-01 |
Normal-vs-Age(41-60Yrs) |
5.202900E-04 |
Normal-vs-Age(61-80Yrs) |
9.68159996617146E-10 |
Normal-vs-Age(81-100Yrs) |
5.335800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.895800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.762800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.064600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.781000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.460600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.350800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.087600E-02 |
Normal-vs-Grade 3 |
6.632500E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.476800E-01 |
Grade 2-vs-Grade 4 |
3.087600E-02 |
Grade 3-vs-Grade 4 |
6.632500E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.69360003588315E-09 |
Normal-vs-N1 |
1.277590E-02 |
N0-vs-N1 |
4.069200E-01 |
|
|